FDA says current dose of GSK-Vir COVID therapy unlikely to work against BA.2 variant
March 25 (Reuters) - The U.S. health regulator said on Friday the current authorized dose of GlaxoSmithKline and Vir Biotechnology's COVID-19 antibody...
March 25 (Reuters) - The U.S. health regulator said on Friday the current authorized dose of GlaxoSmithKline and Vir Biotechnology's COVID-19 antibody...